How has Citigroup's non-marketable equity securities impairment changed year-over-year?

Citigroup's non-marketable equity securities impairment decreased by 55.8% year-over-year, from $52M to $23M.

Citigroup C Non-Marketable Equity Securities Impairment

Non-Marketable Equity Securities Impairment at other companies

Ally FinancialALLY

$38M+5.6%

Rockwell AutomationROK

$10M+42.9%

Baxter InternationalBAX

$0—

EvercoreEVR

$2.03M—

Allison Transmission HoldingsALSN

$0—

General MillsGIS

——

Other financials

Income statement

See full

Revenue$24.6B+14.1%

Net income$5.8B+42.3%

EPS (diluted)$3.06+56.1%

Balance sheet

See full

Cash & equivalents$385.72B+25.1%

Total debt$396.86B+12.5%

Total equity$210.96B-0.7%

Total assets$2.78T+8.0%

Cash flow

See full

Operating cash flow-$21.9B+62.7%

CapEx$1.4B-6.7%

Free cash flow-$23.3B+61.3%

Valuation

See full

Market cap$244B+48.5%

Enterprise value$255.14B+17.7%

P/E15.2×+2.9×

P/S2.8×+0.7×

Profitability

See full

Gross margin76.6%—

Net margin18.2%+1.7pp

FCF margin-71.1%—

Returns & leverage

See full

Return on equity7.6%+1.2pp

Debt / equity1.9×+0.2×

Where this comes from

Reported directly by Citigroup in its filing.

Tagged under the XBRL concept us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount.

The official record: Citigroup’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Citigroup's non-marketable equity securities impairment.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Citigroup's non-marketable equity securities impairment?: Citigroup (C) reported non-marketable equity securities impairment of $23M in Q1 2026.
How has Citigroup's non-marketable equity securities impairment changed year-over-year?: Citigroup's non-marketable equity securities impairment decreased by 55.8% year-over-year, from $52M to $23M.